Eldon C. Mayer III, Director at Eiger BioPharmaceuticals, Inc. (EIGR), bought 21,000 shares at $9.75 ($208K) on 2018-11-26, disclosed to the SEC on 2018-11-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.07 | 6,000 | $60K | 29.1% |
| 2 | $9.75 | 7,500 | $73K | 35.2% |
| 3 | $9.92 | 7,500 | $74K | 35.8% |
| Total | $9.90 avg | 21,000 | $208K | 100% |
| Filing → |
| EIGR | SELL | 2022-01-11 | $8K | — | Filing → |
| EIGR | SELL | 2021-01-11 | $20K | — | Filing → |
| EIGR | BUY | 2020-01-30 | $68K | — | Filing → |